4.7 Review

Laboratory Diagnosis of Infective Endocarditis

Journal

JOURNAL OF CLINICAL MICROBIOLOGY
Volume 55, Issue 9, Pages 2599-2608

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/JCM.00635-17

Keywords

clinical microbiology; endocarditis

Categories

Funding

  1. BioFire
  2. Check-Points
  3. Curetis
  4. 3M
  5. Merck
  6. Hutchison Biofilm Medical Solutions
  7. Accelerate Diagnostics
  8. Allergan
  9. The Medicines Company
  10. ASM
  11. IDSA
  12. Samsung

Ask authors/readers for more resources

Infective endocarditis is life-threatening; identification of the underlying etiology informs optimized individual patient management. Changing epidemiology, advances in blood culture techniques, and new diagnostics guide the application of laboratory testing for diagnosis of endocarditis. Blood cultures remain the standard test for microbial diagnosis, with directed serological testing (i.e., Q fever serology, Bartonella serology) in culture-negative cases. Histopathology and molecular diagnostics (e.g., 16S rRNA gene PCR/sequencing, Tropheryma whipplei PCR) may be applied to resected valves to aid in diagnosis. Herein, we summarize recent knowledge in this area and propose a microbiologic and pathological algorithm for endocarditis diagnosis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available